Why aren't saliva tests more widely used?

Widespread use of saliva tests is currently limited by their cost, which ranges from $100 to $200, and the fact that they are often not covered by insurance.

Will Medicare cover saliva tests in the future?

Yes, Congress recently mandated that Medicare cover FDA-approved multicancer detection tests, which is expected to incentivize companies to obtain FDA approval for their saliva-based diagnostics.

Home / Health / Future of Diagnostics: Saliva Replaces Blood Tests

Future of Diagnostics: Saliva Replaces Blood Tests

Q: What diseases can saliva tests detect?

Saliva tests can detect viruses such as HIV and COVID-19, assess genetic risks for breast cancer, and are being developed for conditions like diabetes and prostate cancer, as well as oral cancers.

20 Feb

•

Summary

Saliva tests can detect viruses, genetic risks, and potentially cancer.
Cost and lack of insurance coverage hinder widespread use currently.
New Medicare coverage incentives boost FDA approval for saliva tests.

Future of Diagnostics: Saliva Replaces Blood Tests

Saliva holds significant microbial information about the body, offering a less invasive alternative to blood samples for disease detection. Current tests can identify viruses like HIV and COVID-19, assess genetic risks for breast cancer, and are being developed for conditions such as diabetes and prostate cancer.

Experts anticipate broader availability of salivary diagnostic tests within a few years, enabling preventative healthcare. However, cost remains a barrier, with current home or dental tests ranging from $100 to $200 and often lacking insurance coverage. This financial aspect is crucial for patient adoption and for companies to invest in the rigorous FDA approval process.